Examination of tumor tissue sections after anti-PD1 therapy demonstrated a co-localization of mast cells and forkhead box P3 (FOXP3)+ Treg cells and this evidence may be associated with a down-modulation of HLA class I on tumor cells. Here, FOXP3 is linked to neoplasm.